EIMI Review (2026): iShares Core MSCI EM IMI UCITS ETF

Disclosure and disclaimer. This article contains affiliate links to brokers. If you open an account through one we may earn a commission at no extra cost to you. Editorial decisions are independent — see our full affiliate disclosure. Nothing here is financial, tax, or legal advice; read our investment disclaimer before acting on anything you read. Past performance does not predict future results. For decisions involving tax, country-specific rules, or your personal circumstances, consult a regulated advisor in your country of residence.

EIMI is the fund that most European investors reach for the moment they decide IWDA alone isn't enough. It is the natural other half of the most-searched DIY two-fund portfolio on this continent: IWDA for developed markets, EIMI for emerging. Pair the two at roughly 88/12 and you've built something structurally very close to VWCE at an almost identical blended cost — but with modular control over the emerging-markets sleeve.

This review is the sister piece to our IWDA review, and it assumes you already know that pairing is why you're here. We walk through fund facts, the IMI small-cap advantage (the thing that actually distinguishes EIMI from vanilla MSCI EM trackers), the 88/12 vs 80/20 weight options with worked examples, country and top-holding concentrations, the China-Taiwan geopolitical reality, country-level tax friction, where to buy, and who should — and should not — own EIMI.

TL;DR — what EIMI is, in one paragraph

EIMI is the iShares Core MSCI EM IMI UCITS ETF USD (Acc), ISIN IE00BKM4GZ66. It holds roughly 3,200 large-, mid- and small-cap companies across emerging markets, market-cap weighted, at a 0.18% total expense ratio. It is Ireland-domiciled, accumulates dividends internally (no cash payout), uses optimised-sampling physical replication, and is — per JustETF — the cheapest and largest UCITS ETF tracking the MSCI EM IMI benchmark. The single differentiator vs vanilla MSCI EM funds is the IMI (Investable Market Index): small-caps are included, giving broader coverage. The canonical use-case is pairing EIMI with IWDA at roughly 88/12 to build a modular two-fund alternative to VWCE.

Not financial advice. This is descriptive, not a recommendation. Past performance does not predict future results. Read the Key Information Document and confirm current TER, AUM and tracking difference on the iShares UK product page or JustETF before you act.

Fund facts — the hard data

Captured from the iShares UK product page, the JustETF profile, Morningstar and the StockAnalysis EIMI holdings list on 2026-04-19.

Field	Value
Full name	iShares Core MSCI EM IMI UCITS ETF USD (Acc)
ISIN	IE00BKM4GZ66
Ticker (LSE, USD)	EIMI
Ticker (Euronext Amsterdam, EUR)	EMIM
Ticker (Borsa Italiana, EUR)	EIMI
TER	0.18%
Distribution policy	Accumulating (ACC)
Domicile	Ireland
Base currency	USD
Fund launch	30 May 2014
Index tracked	MSCI Emerging Markets Investable Market Index (IMI)
Replication method	Physical — optimised sampling
Holdings	~3,200
Issuer	BlackRock Asset Management Ireland
KID available	Yes (PRIIPs-compliant)

Methodology note. All figures above were verified against the iShares UK EIMI product page, JustETF and StockAnalysis.com on 2026-04-19. AUM fluctuates weekly and TER is reviewed by the issuer periodically. Always re-check on the issuer or JustETF profile before investing.

The ticker question — EIMI vs EMIM

Like IWDA, EIMI has more than one ticker because iShares lists the same fund on multiple European exchanges. The Lightyear EMIM vs EIMI compare tool is unambiguous: "EMIM and EIMI track the same security, and so are effectively the same fund. However, EMIM is traded in euros on the Euronext Amsterdam."

Ticker	Listing	Currency	ISIN
EIMI	London Stock Exchange	USD	IE00BKM4GZ66
EMIM	Euronext Amsterdam	EUR	IE00BKM4GZ66
EIMI	Borsa Italiana	EUR	IE00BKM4GZ66

Plain English: same fund, three quote currencies. Pick whichever your broker lists commission-free in your deposit currency. For a UK investor going through Trading 212 or DeGiro, that's usually EIMI on LSE in GBP or USD. For a Eurozone investor it's usually EMIM on Euronext Amsterdam.

What's inside EIMI — countries, sectors, top holdings

EIMI tracks the MSCI Emerging Markets Investable Market Index. As of early 2026, using figures from the iShares UK product page, Investors Chronicle EIMI tearsheet, FT Markets and Investing.com regional breakdown:

Regional split (approximate, per Investing.com):

• Asia — ~80.3%
• Australasia — ~8.7%
• Latin America — ~7.3%
• Europe Emerging — ~2.3%
• North America — ~0.9%
• Europe Developed — ~0.6%

Country split (approximate):

• China — ~28-30%
• Taiwan — ~17-18%
• India — ~17-18%
• South Korea — ~8-9%
• Brazil — ~3-4%
• Saudi Arabia, South Africa, Mexico, Thailand, UAE, Indonesia, Malaysia — remainder spread thinly

Top holdings (a sample; per Investors Chronicle, FT Markets and Morningstar):

Holding	Approx. weight	Country
Taiwan Semiconductor Manufacturing (TSMC)	~11.6%	Taiwan
Samsung Electronics	~4.6%	South Korea
Tencent Holdings	top-10	China
Alibaba Group Holding	~2.3%	China
HDFC Bank	~0.8%	India
Reliance Industries	~0.7%	India
China Construction Bank	~0.7-0.8%	China
Hon Hai Precision Industry	~0.7%	Taiwan

Sector tilt: ~24-26% Technology (TSMC + Samsung + Tencent skew this heavily), ~20-22% Financials, ~10-12% Consumer Discretionary, ~7-8% Communication Services, the rest spread across Industrials, Materials, Consumer Staples, Energy, Health Care, Utilities, Real Estate.

Three things to notice:

1. Top-holding concentration is modest at the fund level but intense at the single-stock level. TSMC alone at ~11.6% is larger than some entire country allocations — per the Investors Chronicle EIMI tearsheet. TSMC is roughly 1 in 9 dollars in the fund.
2. China is the largest country but not dominant. ~28-30% is real concentration, but not majority. The idea that EIMI is "mostly China" is out of date — India and Taiwan together are larger.
3. Small-cap inclusion is the quiet advantage. Around 14% of EIMI sits in small-cap emerging-market names the vanilla MSCI EM ETFs (SEMA, XMME) don't hold at all.

The IMI advantage — what "Investable Market" actually means

This is the detail buried in every competitor page. IMI stands for Investable Market Index. In MSCI's nomenclature, that phrase means the index covers approximately 99% of the investable free-float market capitalisation — which translates to: large-cap + mid-cap + small-cap.

Vanilla MSCI Emerging Markets (the index tracked by iShares' SEMA/IE00B4L5YC18, Amundi's XMME etc.) only covers large + mid. That is roughly 85% of the investable EM universe, leaving small-cap out.

EIMI closes that gap. Per the iShares factsheet the fund holds ~3,200 stocks versus ~1,400 for vanilla MSCI EM — the extra ~1,800 are the small-cap tier.

Why the IMI tier matters.

• Broader diversification. More stocks, more issuer diversification.
• Higher potential return, higher volatility. Small-cap historically runs with a modest risk premium over large-cap over decades.
• Matches the IMI philosophy across your portfolio. If you already own something like SPYI (MSCI ACWI IMI) or you believe in full-market coverage, the IMI tier is consistent.

The trade-off. Slightly higher tracking complexity and slightly higher volatility inside the EM sleeve. At a 12% portfolio weight, the practical effect is small — but it's the reason EIMI tends to outrank SEMA for the DIY Boglehead crowd.

The IWDA + EIMI pair strategy — the core use-case

This is the primary reason the typical European DIY investor opens an EIMI position. The strategy is straightforward and covered at length in our IWDA review sister article:

• Buy IWDA for developed-market equity (MSCI World, ~1,500 stocks, 23 developed countries, 0.20% TER)
• Buy EIMI for emerging-market equity (MSCI EM IMI, ~3,200 stocks, 0.18% TER)
• Target weights determined by conviction

Weight options — the three common choices

Weighting	IWDA	EIMI	Rationale
Market-cap (default)	88%	12%	Matches MSCI ACWI developed/EM split. The "neutral" choice.
Moderate EM tilt	80%	20%	Slight overweight to EM on conviction of long-run EM outperformance.
Strong EM tilt	70%	30%	Bogleheads reference weight — "reduces the US country weight to about 40% and almost triples the China weight."

None of these is "correct" — it's a conviction call. The Bogleheads forum thread makes this explicit: "70% MSCI World / 30% MSCI Emerging Markets seems to be a common split. This reduces the US country weight to about 40% and almost triples the China weight." If you do tilt to EM, you are actively betting against current market-cap weightings — that's a choice, not a default.

Worked example — €10,000 at 88/12

• IWDA: €10,000 × 0.88 = €8,800
• EIMI: €10,000 × 0.12 = €1,200
• Blended TER: (0.88 × 0.20%) + (0.12 × 0.18%) = 0.198% — effectively identical to VWCE's 0.19%

Why the pair vs just buying VWCE?

Pair is better when:

• You want modular control — the freedom to tilt EM weight up or down based on your own view.
• You already own a developed-markets fund (IWDA, CSPX, VUSA, SWRD) and just need to bolt on the EM sleeve.
• You are building the three-fund Boglehead setup (IWDA + EIMI + bonds) — detailed in our three-fund portfolio for Europeans pillar.

VWCE is better when:

• You want one fund, one line on your broker statement, zero rebalancing work.
• You will forget to rebalance — the pair only works if you actually do rebalance periodically.
• Your broker charges per trade and every extra fund multiplies execution friction.

There is no clean winner. It is a preference between control and simplicity — exactly the same trade-off we discuss in the VWCE review.

China and Taiwan — the geopolitical honesty section

Every diligent EIMI review has to name this. The single largest country in EIMI is China (~28-30%); the single largest stock is TSMC, a Taiwanese semiconductor company that is critical to the global supply chain (~11.6% of the fund). MSCI periodically reviews Chinese equity inclusion; sanctions and tariff regimes are an active geopolitical dynamic.

What this means in practice:

• China drawdowns hit EIMI hard. 2021-2022 Chinese regulatory crackdowns dragged EIMI's EM sleeve for several quarters.
• Taiwan-China escalation risk is real. A blockade or worse around Taiwan would impact TSMC — EIMI's largest single holding — and therefore roughly 12% of every euro you have invested in EIMI directly.
• Diversification limits. EIMI diversifies within emerging markets, but it cannot diversify away the category-level geopolitics.

The retireby50.me portfolio thought-process flags this concern in a useful way: the China weight is big enough that investors uncomfortable with it have turned to EM-ex-China funds like EXCS instead. That is a legitimate alternative.

How "accumulating" actually works

Same mechanic as IWDA and VWCE. When EIMI's underlying companies pay dividends, those dividends are received by the fund, not by you. BlackRock reinvests them inside the fund, buying more index constituents. NAV grows; share count stays constant; each share becomes worth slightly more. You never see a dividend cash line on your broker statement; compounding happens inside the fund at zero execution cost.

This is tax-efficient in most EU jurisdictions — but not all. Country-by-country mechanics in our accumulating vs distributing ETFs guide.

Country tax brief — six European jurisdictions

A summary, not advice. Country tax rules change; consult a regulated advisor in your country of residence.

• Germany. Gains taxed via Vorabpauschale; Teilfreistellung shields 30% of equity-fund income. EIMI qualifies as an equity fund — broadly tax-efficient.
• Netherlands. Box 3 wealth tax (fictitious return). EIMI's accumulating structure does not materially affect Box 3 treatment. Under reform — check Belastingdienst current methodology.
• Belgium. 1.32% TOB on every buy and sell of accumulating Ireland-domiciled ETFs (EIMI included). No tax on accumulated dividends within the fund.
• Ireland. 41% exit tax on gains; 8-year deemed disposal crystallises tax even without sale — see Revenue.ie.
• UK. EIMI holds UK reporting fund status (verify on HMRC register). ISA and SIPP wrappers shelter gains entirely.
• France. Outside a PEA, EIMI sits in a CTO — 30% flat PFU on realisation. ACC defers tax until sale.

Full walk-through: our accumulating vs distributing pillar.

Where to buy EIMI

EIMI is on the shelf at every major European broker. Most common routes:

• Trading 212 ([#affiliate-trading212]) — Commission-free on most European exchanges, fractional shares, AutoInvest with Pies for recurring DCA into EIMI. The path of least resistance for a first EIMI purchase, particularly as a fractional top-up alongside IWDA.
• DeGiro ([#affiliate-degiro]) — EIMI has historically been on the DeGiro ETF Core Selection free list in several markets (one free trade per month per Core ETF, above a minimum size). Verify current inclusion on DeGiro's market-specific Core Selection list before buying — the list is refreshed periodically. No fractional shares.
• Interactive Brokers ([#affiliate-ibkr]) — Cheapest on larger volume, tiered pricing, great for the rebalance-annually Boglehead who wants to bank low execution costs. Steeper UX than T212.
• Lightyear ([#affiliate-lightyear]) — Newer EU broker with commission-free ETFs on a curated list, fractional support, clean UX; maintains both EIMI and IWDA comparison tools.

For the full broker decision, see Trading 212 vs DeGiro. For the end-to-end "open account → first buy" sequence, see our how-to-start-investing-in-ETFs-as-a-European pillar.

Historical performance — what the data shows

Per Morningstar, JustETF and TradingView, EIMI has delivered roughly 6-7% annualised USD since its 2014 inception — meaningfully below IWDA's developed-market 10-11% over the overlapping period. Morningstar's analyst note frames this plainly: "IShares Core MSCI Emerging Markets IMI ETF's main strength is its low fee, which makes it a solid option for investors seeking emerging-markets equity exposure." Trailing-year to early 2026, TradingView reports EIMI up roughly 50%+ — a snapshot within a strong EM recovery run; do not extrapolate.

Three caveats. (1) Past performance does not predict future results — the 2014-2024 window had prolonged EM underperformance; the next decade may or may not mirror that. (2) EM returns are especially USD-dependent — FX swings explain a meaningful share of your realised return. (3) EIMI's 2014 inception means its full-cycle history is short; most of the "decades of EM data" you read online uses longer-running underlying index series, not EIMI itself.

Risks and honest weaknesses

Five risks named explicitly:

1. China concentration + geopolitical risk. ~28-30% of the fund in China, plus ~12% in TSMC. Taiwan-China escalation would hit EIMI disproportionately.
2. High single-stock concentration. TSMC at ~11.6% of the fund is unusually large for a 3,200-holding ETF. It is concentration by market-cap weighting, not by manager choice — but it is still concentration.
3. Historical underperformance vs developed markets. EM has trailed DM for most of the last 10-15 years. That's the exact reason market-cap weight is only 12% — the pie has shrunk.
4. Currency risk. EM currencies (INR, BRL, TRY, ZAR, etc.) are volatile vs USD/EUR. Some of your drawdowns will be FX-driven.
5. Small-cap drag. IMI inclusion helps diversification but adds volatility — fine at 12% portfolio weight, less fine if you overweight EIMI aggressively.

Pros and cons

Pros.

• Very low TER (0.18%) — cheapest and largest UCITS ETF tracking MSCI EM IMI per JustETF.
• Accumulating = zero-friction compounding in most jurisdictions.
• Ireland-domiciled = efficient tax-treaty withholding on US-denominated dividends.
• ~3,200 holdings — broadest available EM coverage in UCITS format.
• IMI small-cap inclusion distinguishes it from vanilla MSCI EM competitors.
• Multiple exchange listings (EIMI LSE, EMIM Amsterdam) — commission-free routes on most European brokers.
• iShares/BlackRock = reputable issuer with deep ETF operational experience.

Cons.

• ~28-30% China exposure + ~12% TSMC means high geopolitical-sensitivity single-stock concentration.
• EM historical returns have lagged developed markets for over a decade.
• Not a one-fund solution — excludes developed markets entirely.
• Small-cap tier adds volatility you may not want at high EIMI weightings.
• Belgium 1.32% TOB applies on every buy/sell.
• Ireland 8-year deemed disposal applies to Irish residents.

Who should buy EIMI

EIMI is a good fit — descriptive, not a recommendation — if most of these apply:

• You already own IWDA (or another developed-markets fund like CSPX, VUSA, SWRD) and want to complete your global equity coverage.
• You are building a two-fund portfolio (IWDA + EIMI at 88/12) or three-fund portfolio (IWDA + EIMI + bonds) and want modular control — see the three-fund portfolio pillar.
• You have conviction that emerging markets will hold or outperform their market-cap weight over your horizon.
• You want IMI-level breadth (small-cap inclusion) in your EM sleeve, not just MSCI EM large/mid.
• 10+ year horizon; comfortable with EM volatility and drawdowns.
• You live in a country where accumulating funds are tax-neutral or efficient (DE, FR outside PEA, NL inside Box 3, UK inside ISA or SIPP).

Confirm the current TER and AUM on JustETF, read the KID, and when in doubt speak to a regulated advisor.

Who should NOT buy EIMI

EIMI is a poor fit if:

• You want one fund that covers everything. EIMI is a sleeve, not a solution. Buy VWCE or SPYI for the one-fund answer.
• You are uncomfortable with China concentration. At ~28-30% China + ~12% TSMC (Taiwan), EIMI is structurally exposed to cross-straits geopolitical risk. Consider an EM-ex-China fund instead.
• You find rebalancing a hassle. The IWDA + EIMI pair only works if you periodically rebalance; if you will forget or deprioritise, VWCE removes that failure mode.
• You don't already have developed-market exposure. EIMI is not a starter ETF. Start with our best UCITS ETFs for beginners guide and build the developed-market core first.
• You want dividend income. EIMI is accumulating — no cash. Look at the distributing MSCI EM share classes if income matters.
• You are close to retirement with no bonds. A 100%-equity EM slice for a short horizon is a known mistake. See three-fund portfolio for Europeans for adding a bond sleeve.

How EIMI fits a complete portfolio

EIMI is almost never the whole portfolio. The most common setups it anchors:

• IWDA + EIMI — equity-only two-fund. 88/12 market-cap default or 80/20 EM-tilt. Covered in detail in our IWDA review.
• IWDA + EIMI + AGGH — the canonical DIY three-fund Boglehead European portfolio. Detailed weights in the three-fund portfolio pillar.
• IWDA + EIMI + WSML — equity all-cap expansion adding developed-market small-caps. Popular in r/eupersonalfinance discussions.
• CSPX + EIMI — if your developed core is S&P 500 instead of MSCI World. See our best UCITS ETFs guide for when that substitution is sensible.

If you are not sure how to wire any of this up — broker choice, KYC, first order, recurring contributions — start with our step-by-step how-to-start-investing-in-ETFs-as-a-European guide.

Bottom line

EIMI is not a standalone answer — it is a complement. Its reason for existing is the moment after you've decided on IWDA and realised you still want emerging-market exposure. At that moment, EIMI is the default choice for most European DIY investors: cheap (0.18% TER), broad (~3,200 holdings), accumulating, Ireland-domiciled, and on the shelf at every major broker.

The IMI tier — the small-cap inclusion — is the quiet edge that separates EIMI from vanilla MSCI EM funds like SEMA or XMME. It is also the reason EIMI tends to be the Boglehead default when the EM sleeve gets discussed.

The honest caveats are the China/Taiwan weight and the decade-long run of EM underperformance relative to developed markets. Neither is a reason to skip EIMI outright; both are reasons to own it in modest weight (market-cap ~12%, EM-tilt ~20%), not oversize.

If you want a one-fund solution, buy VWCE and stop reading. If you want modular control of the global portfolio, pair IWDA with EIMI at a weight you can defend, rebalance annually, and ignore the noise.

Either way: confirm numbers on JustETF, match yourself to the lists above, and talk to a regulated advisor if tax or personal circumstances are at stake.

Disclaimer (repeated). Nothing in this article is financial, tax, or legal advice. All figures were verified on 2026-04-19 against the iShares UK EIMI product page, JustETF's IE00BKM4GZ66 profile, Morningstar, Investors Chronicle, FT Markets and StockAnalysis.com. ETF data changes; re-check before you act. Past performance does not predict future results. For country-specific or personal-circumstance decisions, consult a regulated advisor in your country of residence.